Avid Bioservices completes construction of ‘world-class’ California cell and gene facility 26-Oct-2023 By Isabel Cameron Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), has completed construction of several CGMP manufacturing suites within its new and gene therapy (CGT) development and CGMP manufacturing facility.
Avid expansion to triple process development capacity, says CEO 25-Oct-2018 By Ben Hargreaves Avid continues its transition to a fully-fledged CDMO by transforming its process development capabilities with new lab space.
